WHO ICTRP trial
Proposal to investigate the efficacy and tolerability of Aripiprazole as an…
EUCTR2006-004605-26-GB · EU Clinical Trials Register · Not Recruiting
Key facts
| Trial ID | EUCTR2006-004605-26-GB |
|---|---|
| Public title | Proposal to investigate the efficacy and tolerability of Aripiprazole as an add-on therapy in patients not responding to an adequate dose of an antidepressant therapy |
| Scientific title | Proposal to investigate the efficacy and tolerability of Aripiprazole as an add-on therapy in patients not responding to an adequate dose of an antidepressant therapy |
| Primary sponsor | Manchester Mental Health &Social Care Trust |
| Registry | EU Clinical Trials Register |
| Recruitment status | Not Recruiting |
| Study type | Interventional clinical trial of medicinal product |
| Phase | Human pharmacology (Phase I): no Therapeutic exploratory (Phase II): no Therapeutic confirmatory - (Phase III): no Therapeutic use (Phase IV): yes |
| Countries | United Kingdom |
| Conditions | Depressive disorder not responding to an adequate dose of an antidepressant MedDRA version: 8.1 Level: LLT Classification code 10025470 Term: Major depressive disorder, single episode, unspecified degree |
| Interventions | Trade Name: Ablify Product Name: Aripiprazole Pharmaceutical Form: Tablet Concentration unit: mg milligram(s) Concentration type: equal Concentration number: 10- Pharmaceutical form of the placebo: Tablet Route of administration of the… |
| Registration date | Jan 14, 2007 |
| Target size | 90 |
| Secondary IDs | DX1954P |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: